Free Trial

OneMedNet (NASDAQ:ONMD) Director Thomas Kosasa Buys 280,898 Shares

OneMedNet logo with Computer and Technology background
Image from MarketBeat Media, LLC.

Key Points

  • Director insider purchase: Thomas Kosasa bought 280,898 shares on April 23 at an average $0.89 per share (~$250,000), raising his stake to 16,661,327 shares (a 1.71% increase); he also purchased 595,238 shares on Feb. 6 at $0.84 (~$500,000).
  • Company valuation and sentiment: OneMedNet recently traded at $1.10 with a $57.6M market cap, negative P/E, 50‑day/200‑day moving averages of $0.79/$1.26, low institutional ownership (~0.95%), and an analyst consensus of Sell (Weiss Ratings reaffirmed a "sell (d-)").
  • MarketBeat previews top five stocks to own in May.

OneMedNet Corporation (NASDAQ:ONMD - Get Free Report) Director Thomas Kosasa purchased 280,898 shares of the stock in a transaction dated Thursday, April 23rd. The stock was bought at an average cost of $0.89 per share, with a total value of $249,999.22. Following the transaction, the director owned 16,661,327 shares in the company, valued at $14,828,581.03. The trade was a 1.71% increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website.

Thomas Kosasa also recently made the following trade(s):

  • On Friday, February 6th, Thomas Kosasa purchased 595,238 shares of OneMedNet stock. The stock was bought at an average cost of $0.84 per share, with a total value of $499,999.92.

OneMedNet Stock Performance

Shares of ONMD traded up $0.21 during trading hours on Friday, hitting $1.10. The company had a trading volume of 821,198 shares, compared to its average volume of 3,251,295. The firm has a fifty day moving average price of $0.79 and a 200-day moving average price of $1.26. The stock has a market capitalization of $57.58 million, a price-to-earnings ratio of -15.76 and a beta of 1.16. OneMedNet Corporation has a 52-week low of $0.31 and a 52-week high of $4.22.

OneMedNet (NASDAQ:ONMD - Get Free Report) last posted its quarterly earnings results on Monday, March 30th. The company reported ($0.07) earnings per share (EPS) for the quarter. The firm had revenue of $0.89 million during the quarter.

Institutional Investors Weigh In On OneMedNet

Several large investors have recently bought and sold shares of the business. Virtu Financial LLC bought a new stake in OneMedNet in the 4th quarter worth about $48,000. State Street Corp increased its holdings in OneMedNet by 41.5% in the 4th quarter. State Street Corp now owns 116,700 shares of the company's stock worth $128,000 after buying an additional 34,200 shares in the last quarter. Jane Street Group LLC bought a new stake in OneMedNet in the 4th quarter worth about $119,000. HRT Financial LP bought a new stake in OneMedNet in the 4th quarter worth about $32,000. Finally, Exencial Wealth Advisors LLC increased its holdings in OneMedNet by 1.3% in the 4th quarter. Exencial Wealth Advisors LLC now owns 3,644,861 shares of the company's stock worth $4,009,000 after buying an additional 45,401 shares in the last quarter. 0.95% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

Separately, Weiss Ratings reaffirmed a "sell (d-)" rating on shares of OneMedNet in a research report on Friday, January 9th. One equities research analyst has rated the stock with a Sell rating, According to MarketBeat.com, OneMedNet has an average rating of "Sell".

View Our Latest Analysis on OneMedNet

OneMedNet Company Profile

(Get Free Report)

OneMedNet Corporation provides clinical imaging solutions. It offers iRWD, a solution that utilizes AI to securely de-identify, search, and curate imaging data for its partner network consisting of medical and academic research institutions to generate progression in stages of medical research, discovery and diagnostics that span the field of life sciences. OneMedNet Corporation is based in Eden Prairie, Minnesota.

Featured Articles

Insider Buying and Selling by Quarter for OneMedNet (NASDAQ:ONMD)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in OneMedNet Right Now?

Before you consider OneMedNet, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and OneMedNet wasn't on the list.

While OneMedNet currently has a Sell rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy Before SpaceX Goes Public Cover

A forward-looking investment report spotlighting the seven space companies best positioned to benefit from accelerating commercialization in 2026. It explores key industry trends, major growth catalysts, and the stocks shaping the next phase of the space economy—from launch leaders and satellite networks to data, defense, and in-space infrastructure.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines